Has Elias Iliadis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $290,041 in general payments to Elias Iliadis, MD across 966 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Elias Iliadis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Elias Iliadis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Elias Iliadis, MD

Cardiovascular Disease · Voorhees, NJNPI 1326133034

Payments from drug & device makers

$290,041in general payments, 2019–2025

Across 966 payments — averaging $300.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Penumbra, Inc.$197K
Johnson & Johnson$37K
AstraZeneca$14K
Boston Scientific$11K
Pfizer$7K
EKOS Corporation$5K
plus $20K from 36 others

$3,192in research payments, 2019–2025

Across 2 payments — averaging $1596.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$3K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Penumbra, Inc.	154	$196,600
Johnson & Johnson	223	$36,548
AstraZeneca	24	$13,780
Boston Scientific	61	$11,447
Pfizer	43	$7,224
EKOS Corporation	2	$4,500
E.r. Squibb & Sons, L.L.C.	47	$4,166
Philips North America LLC	11	$2,689
Abiomed	50	$2,059
Abbott	77	$1,395
Inari Medical, Inc.	22	$916
Artivion, Inc.	1	$858
Shockwave Medical, Inc	5	$852
Medtronic(2 entities)	15	$784
Cardiovascular Systems Inc.	19	$771
Atricure, Inc.	20	$738
Amgen	46	$728
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	17	$479
Alnylam Pharmaceuticals Inc.	12	$423
Terumo Medical Corporation	4	$372
Biosense Webster, Inc.	15	$347
Boehringer Ingelheim	13	$304
Cardiva Medical, Inc.	7	$270
Novartis	18	$250
Angiodynamics, Inc.	3	$219
Merck	14	$205
Chiesi USA, Inc.	11	$198
Kestra Medical Technology Services, Inc.	2	$191
W. L. Gore & Associates, Inc.	11	$170
Bard Peripheral Vascular, Inc.	1	$140
Janssen Scientific Affairs, LLC	1	$120
Actelion Pharmaceuticals US, Inc.	3	$48
Cardinal Health 200 LLC	2	$41
Cvrx, Inc.	3	$40
Stryker	2	$32
Change Healthcare Technologies, LLC	1	$25
Vital Connect, Inc	1	$25
Cordis US CORP.	1	$20
Siemens Medical Solutions USA, Inc.	1	$19
Regeneron Healthcare Solutions, Inc.	1	$17
Bayer	1	$16
Kiniksa Pharmaceuticals, Ltd.	1	$14

How this compares

$290,041 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey →

Medicare billing

Part B allowed, 2024

$295,389

Medicare patients

959

Services billed

2,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Voorhees

Joseph ParrilloVoorhees$209K
Richard PerlmanVoorhees$183K
Robert KippermanMorristown$5.3M
Sharan MahalBridgewater$3.5M
Linda GillamMorristown$2.2M
Mark GelerntHaddon Heights$2M
Robert FishbergSpringfield$1.9M
Dilip ViswanathHaddon Heights$1.8M
Marc CohenNewark$1M
Jasjit WaliaElizabeth$859K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →